| Patent | Date |
|---|
Biomarker For Assessing The Risk Of Developing Acute Covid-19 And Post-acute Covid-19
App 20220308056 - Demopulos; Gregory A. ; et al. | 2022-09-29 |
Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders
App 20220259325 - Schwaeble; Hans-Wilhelm ; et al. | 2022-08-18 |
Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria
App 20220242972 - Demopulos; Gregory A. ; et al. | 2022-08-04 |
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
App 20220089781 - Demopulos; Gregory A. ; et al. | 2022-03-24 |
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
App 20220002439 - Demopulos; Gregory A. ; et al. | 2022-01-06 |
Methods For Inhibiting Fibrosis In A Subject In Need Thereof
App 20210355236 - Brunskill; Nigel John ; et al. | 2021-11-18 |
Methods for Treating and/or Preventing Graft-Versus-Host Disease and/or Diffuse Alveolar Hemorrhage and/or Veno-Occlusive Disease Associated with Hematopoietic Stem Cell Transplant
App 20210290684 - Demopulos; Gregory A. ; et al. | 2021-09-23 |
Methods For Inhibiting Angiogenesis In A Subject In Need Thereof
App 20210189009 - Demopulos; Gregory A. ; et al. | 2021-06-24 |
Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant
Grant 11,013,772 - Demopulos , et al. May 25, 2 | 2021-05-25 |
Methods For Reducing Proteinuria In A Human Subject Suffering From Immunoglobulin A Nephropathy
App 20210079116 - Brunskill; Nigel John ; et al. | 2021-03-18 |
Methods For Inhibiting Fibrosis In A Subject In Need Thereof
App 20210077621 - Brunskill; Nigel John ; et al. | 2021-03-18 |
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
App 20210054098 - Demopulos; Gregory A. ; et al. | 2021-02-25 |
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
App 20210047433 - Demopulos; Gregory A. ; et al. | 2021-02-18 |
Methods For Treating Conditions Associated With Masp-2 Dependent Complement Activation
App 20210040229 - Schwaeble; Hans-Wilhelm ; et al. | 2021-02-11 |
Methods for inhibiting angiogenesis in a subject in need thereof
Grant 10,870,708 - Demopulos , et al. December 22, 2 | 2020-12-22 |
Monoclonal Antibodies, Compositions and Methods for Detecting Mucin-like Protein (MLP) as a Biomarker for Ovarian and Pancreatic Cancer
App 20200369782 - Schwaeble; Hans-Wilhelm ; et al. | 2020-11-26 |
Methods for inhibiting fibrosis in a subject in need thereof
Grant 10,736,960 - Brunskill , et al. A | 2020-08-11 |
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
App 20200190215 - Schwaeble; Hans-Wilhelm ; et al. | 2020-06-18 |
Genetically modified non-human mammals and cells
Grant 10,660,317 - Fujita , et al. | 2020-05-26 |
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
App 20200157244 - Demopulos; Gregory A. ; et al. | 2020-05-21 |
Methods For Treating Conditions Associated With Masp-2 Dependent Complement Activation
App 20200157245 - Schwaeble; Hans-Wilhelm ; et al. | 2020-05-21 |
Monoclonal antibodies, compositions and methods for detecting mucin-like protein (MLP) as a biomarker for ovarian and pancreatic cancer
Grant 10,626,184 - Schwaeble , et al. | 2020-04-21 |
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
App 20200048366 - Demopulos; Gregory A. ; et al. | 2020-02-13 |
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
App 20200040104 - Demopulos; Gregory A. ; et al. | 2020-02-06 |
Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Paroxysmal Nocturnal Hemoglobinur
App 20190382505 - Schwaeble; Hans-Wilhelm ; et al. | 2019-12-19 |
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
App 20190292272 - Demopulos; Gregory A. ; et al. | 2019-09-26 |
Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders
App 20190127484 - Schwaeble; Hans-Wilhelm ; et al. | 2019-05-02 |
Methods for Treating and/or Preventing Graft-Versus-Host Disease and/or Diffuse Alveolar Hemorrhage and/or Veno-Occlusive Disease Associated with Hematopoietic Stem Cell Transplant
App 20190125802 - Demopulos; Gregory A. ; et al. | 2019-05-02 |
Methods for treating conditions associated with MASP-2 dependent complement activation
Grant 10,202,465 - Demopulos , et al. Feb | 2019-02-12 |
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
App 20190016824 - Demopulos; Gregory A. ; et al. | 2019-01-17 |
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
App 20180291111 - Demopulos; Gregory A. ; et al. | 2018-10-11 |
Methods for Treating Disseminated Intravascular Coagulation by Inhibiting MASP-2 Dependent Complement Activation
App 20180291112 - Schwaeble; Hans-Wilhelm ; et al. | 2018-10-11 |
Methods for treating conditions associated with MASP-2 dependent complement activation
Grant 10,059,776 - Demopulos , et al. August 28, 2 | 2018-08-28 |
Compositions and Methods of Inhibiting MASP-3 for the Treatment of Various Diseases and Disorders
App 20180140697 - Cummings; W. Jason ; et al. | 2018-05-24 |
Methods For Reducing Proteinuria In A Human Subject Suffering From Immunoglobulin A Nephropathy
App 20180105604 - Brunskill; Nigel John ; et al. | 2018-04-19 |
Monoclonal Antibodies, Compositions and Methods for Detecting Mucin-like Protein (MLP) as a Biomarker for Ovarian and Pancreatic Cancer
App 20170355777 - Schwaeble; Hans-Wilhelm ; et al. | 2017-12-14 |
Methods for Inhibiting Angiogenesis in a Subject in Need Thereof
App 20170283508 - Demopulos; Gregory A. ; et al. | 2017-10-05 |
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
App 20170267781 - Demopulos; Gregory A. ; et al. | 2017-09-21 |
Methods For Inhibiting Fibrosis In A Subject In Need Thereof
App 20170253667 - Brunskill; Nigel John ; et al. | 2017-09-07 |
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
App 20170233493 - Schwaeble; Hans-Wilhelm ; et al. | 2017-08-17 |
Methods for Treating Disseminated Intravascular Coagulation by Inhibiting MASP-2 Dependent Complement Activation
App 20170233494 - Schwaeble; Hans-Wilhelm ; et al. | 2017-08-17 |
Methods for Inhibiting Fibrosis in a Subject in Need Thereof
App 20170189525 - Brunskill; Nigel John ; et al. | 2017-07-06 |
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
App 20170166660 - Schwaeble; Hans-Wilhelm ; et al. | 2017-06-15 |
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
App 20170166658 - Demopulos; Gregory A. ; et al. | 2017-06-15 |
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
App 20170166659 - Demopulos; Gregory A. ; et al. | 2017-06-15 |
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
App 20170137537 - Demopulos; Gregory A. ; et al. | 2017-05-18 |
Genetically Modified Non-human Mammals And Cells
App 20170127657 - Fujita; Teizo ; et al. | 2017-05-11 |
Methods for treating conditions associated with MASP-2 dependent complement activation
Grant 9,644,035 - Demopulos , et al. May 9, 2 | 2017-05-09 |
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
App 20160272727 - Demopulos; Gregory A. ; et al. | 2016-09-22 |
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
App 20150239985 - Demopulos; Gregory A. ; et al. | 2015-08-27 |
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
App 20150166675 - Demopulos; Gregory A. ; et al. | 2015-06-18 |
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
App 20150166676 - Demopulos; Gregory A. ; et al. | 2015-06-18 |
Genetically Modified Non-human Mammals And Cells
App 20150067897 - Fujita; Teizo ; et al. | 2015-03-05 |
Methods For Treating Conditions Associated With Masp-2 Dependent Complement Activation
App 20150064176 - Schwaeble; Hans-Wilhelm ; et al. | 2015-03-05 |
Methods for treating conditions associated with MASP-2 dependent complement activation
Grant 8,951,522 - Demopulos , et al. February 10, 2 | 2015-02-10 |
Methods For Treating Properdin-related Diseases Or Disorders
App 20150038420 - Schwaeble; Hans-Wilhelm ; et al. | 2015-02-05 |
Methods for treating conditions associated with MASP-2 dependent complement activation
Grant 8,840,893 - Schwaeble , et al. September 23, 2 | 2014-09-23 |
Methods for Treating Disseminated Intravascular Coagulation by Inhibiting MASP-2 Dependent Complement Activation
App 20140205598 - Schwaeble; Hans-Wilhelm ; et al. | 2014-07-24 |
Genetically modified non-human mammals and cells
Grant 8,785,717 - Fujita , et al. July 22, 2 | 2014-07-22 |
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
App 20140056873 - Schwaeble; Hans-Wilhelm ; et al. | 2014-02-27 |
Methods for treating disseminated intravascular coagulation by inhibiting MASP-2 dependent complement activation
Grant 8,652,477 - Schwaeble , et al. February 18, 2 | 2014-02-18 |
Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Various Diseases and Disorders
App 20130344073 - Schwaeble; Hans-Wilhelm ; et al. | 2013-12-26 |
Compositions and Methods of Inhibiting MASP-1 and/or MASP-2 and/or MASP-3 for the Treatment of Paroxysmal Nocturnal Hemoglobinuria
App 20130273053 - Schwaeble; Hans-Wilhelm ; et al. | 2013-10-17 |
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
App 20130266559 - Demopulos; Gregory A. ; et al. | 2013-10-10 |
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
App 20130266560 - Demopulos; Gregory A. ; et al. | 2013-10-10 |
Methods for Treating Conditions Associated with MASP-2 Dependent Complement Activation
App 20120258095 - Demopulos; Gregory A. ; et al. | 2012-10-11 |
Methods For Treating Conditions Associated With Masp-2 Dependent Complement Activation
App 20110311549 - Schwaeble; Hans-Wilhelm ; et al. | 2011-12-22 |
Methods For Treating Disseminated Intravascular Coagulation By Inhibiting Masp-2 Dependent Complement Activation
App 20110091450 - Schwaeble; Hans-Wilhelm ; et al. | 2011-04-21 |
Methods for treating conditions associated with MASP-2 dependent complement activation
Grant 7,919,094 - Schwaeble , et al. April 5, 2 | 2011-04-05 |
Methods For Treating Conditions Associated With Masp-2 Dependent Complement Activation
App 20110020337 - Schwaeble; Hans-Wilhelm ; et al. | 2011-01-27 |
Methods For Treating Conditions Associated With Masp-2 Dependent Complement Activation
App 20100074899 - Schwaeble; Hans-Wilhelm ; et al. | 2010-03-25 |
Masp-2, A Complement Fixing Enzyme, And Uses For It
App 20090259019 - Willis; Anthony C. ; et al. | 2009-10-15 |
Genetically Modified Non-human Mammals And Cells
App 20090205058 - Fujita; Teizo ; et al. | 2009-08-13 |
Methods for treating conditions associated with MASP-2 dependent complement activation
App 20070172483 - Schwaeble; Hans-Wilhelm ; et al. | 2007-07-26 |
Methods for treating conditions associated with lectin-dependent complement activation
App 20060018896 - Schwaeble; Hans-Wilhelm ; et al. | 2006-01-26 |
Methods for treating conditions associated with MASP-2 dependent complement activation
App 20060002937 - Schwaeble; Hans-Wilhelm ; et al. | 2006-01-05 |
| 